Trials / Conditions / Anti-MAG Neuropathy
Anti-MAG Neuropathy
5 registered clinical trials studyying Anti-MAG Neuropathy — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Studying Nerve Function and Structure in Charcot-Marie-Tooth Disease, Anti-MAG Neuropathy and CIDP NCT07461896 | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | — |
| Recruiting | Rituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good Responders NCT05136976 | Centre Hospitalier Universitaire de Saint Etienne | Phase 3 |
| Terminated | First in Human Study to Test the Safety and Preliminary Efficacy of PPSGG in Patients With Anti-MAG Neuropathy NCT04568174 | Polyneuron Pharmaceuticals AG | Phase 1 / Phase 2 |
| Completed | Quantification of Nerve Stiffness in Neuropathies NCT03397303 | Nantes University Hospital | N/A |
| Completed | SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study NCT02967679 | MedDay Pharmaceuticals SA | Phase 2 |